Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,298 Million (Micro Cap)
11.00
NA
2.87%
-0.06
10.15%
1.16
Revenue and Profits:
Net Sales:
331 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
31.41%
0%
31.41%
6 Months
25.43%
0%
25.43%
1 Year
42.3%
0%
42.3%
2 Years
5.13%
0%
5.13%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shandong Sinoglory Health Food Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-9.95%
EBIT Growth (5y)
3.34%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
1.45
Tax Ratio
23.38%
Dividend Payout Ratio
15.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.40%
ROE (avg)
9.43%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
1.16
EV to EBIT
9.11
EV to EBITDA
6.60
EV to Capital Employed
1.17
EV to Sales
0.89
PEG Ratio
1.50
Dividend Yield
2.87%
ROCE (Latest)
12.82%
ROE (Latest)
10.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
330.70
383.80
-13.84%
Operating Profit (PBDIT) excl Other Income
51.70
38.00
36.05%
Interest
0.20
0.10
100.00%
Exceptional Items
0.00
0.20
-100.00%
Consolidate Net Profit
26.60
26.60
Operating Profit Margin (Excl OI)
102.80%
77.00%
2.58%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -13.84% vs -1.31% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 0.00% vs -14.47% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,477.80
1,682.70
-12.18%
Operating Profit (PBDIT) excl Other Income
157.60
171.10
-7.89%
Interest
1.10
1.90
-42.11%
Exceptional Items
0.00
-1.00
100.00%
Consolidate Net Profit
109.10
110.10
-0.91%
Operating Profit Margin (Excl OI)
84.20%
81.20%
0.30%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -12.18% vs 4.87% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -0.91% vs -3.76% in Dec 2023
About Shandong Sinoglory Health Food Co. Ltd. 
Shandong Sinoglory Health Food Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






